A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Police said 375 people attended a rally in Newcastle by the anti-Islam group Pegida, while 2000 people joined a counter-demonstration.
Kelly Osbourne has quit Fashion Police after the E! show came under fire over a comment Giuliana Rancic made about Zendaya's dreadlocks.
The death of Boris Nemtsov hits particularly hard because he represented what post-Communist Russia might have become.